Stay informed with the latest updates for the inheritable blood disorders community. Industry Catalyst Updates on Phase 2/3 Trial of Subcutaneous TherapyAug 17, 2018 Industry Sangamo Reports Positive Preliminary Data from Hemophilia Gene Therapy…Aug 9, 2018 Industry Spark Reports Progress on Hemophilia A Gene TherapyAug 8, 2018 Industry Court Rules on Shire/Roche Preliminary InjunctionAug 8, 2018 Industry Pfizer Initiates First Stage of Phase 3 Hemophilia B Gene Therapy TrialJul 17, 2018 Industry Catalyst’s Trial Update Includes Reports of Antibody ResponsesJun 18, 2018 Industry HEMLIBRA® Granted Priority Review by FDAJun 6, 2018 Industry FDA Approves New Vial Size for Idelvion® Jun 5, 2018 Industry uniQure Reports Successful Delivery of FIX Gene Therapy Despite Antibodies…Jun 4, 2018 Industry Genentech Announces Positive HEMLIBRA Trial ResultsMay 23, 2018 Industry Spark Sees Continued Progress in Hemophilia B Gene TherapyMay 23, 2018 Industry HEMLIBRA® Receives Breakthrough Designation from FDAApr 17, 2018 Industry ICER Review of Emicizumab for People with Hemophilia A and InhibitorsApr 16, 2018 Industry Grifols Announces 2017 Factor Product Donations to WFH Humanitarian…Apr 16, 2018 Industry Statement from Genentech Regarding HemlibraMar 28, 2018 Pagination First page Previous page … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page Last page